CASTLE BIOSCIENCES INC's ticker is CSTL and the CUSIP is 14843C105. A total of 130 filers reported holding CASTLE BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 2.44 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $607,314 | +86.6% | 35,957 | +51.6% | 0.00% | – |
| Q2 2023 | $325,425 | -37.5% | 23,719 | +3.6% | 0.00% | – |
| Q1 2023 | $520,402 | +15.6% | 22,905 | +19.8% | 0.00% | – |
| Q4 2022 | $450,155 | -95.0% | 19,123 | -94.5% | 0.00% | -100.0% |
| Q3 2022 | $9,023,000 | +17.8% | 345,979 | -0.8% | 0.00% | +50.0% |
| Q2 2022 | $7,658,000 | -84.2% | 348,862 | -67.7% | 0.00% | -83.3% |
| Q1 2022 | $48,405,000 | +7.6% | 1,079,032 | +2.8% | 0.01% | +9.1% |
| Q4 2021 | $45,000,000 | -34.4% | 1,049,660 | +1.7% | 0.01% | -35.3% |
| Q3 2021 | $68,605,000 | -17.8% | 1,031,658 | -9.4% | 0.02% | -19.0% |
| Q2 2021 | $83,468,000 | +18.8% | 1,138,252 | +10.9% | 0.02% | +10.5% |
| Q1 2021 | $70,288,000 | -6.5% | 1,026,705 | -8.3% | 0.02% | -13.6% |
| Q4 2020 | $75,149,000 | +1653.4% | 1,119,123 | +1243.4% | 0.02% | +2100.0% |
| Q3 2020 | $4,286,000 | +571.8% | 83,304 | +391.8% | 0.00% | – |
| Q2 2020 | $638,000 | – | 16,937 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ABG Innovation Capital Partners III GP Ltd | 33,626 | $567,943 | 77.21% |
| Millrace Asset Group, Inc. | 77,315 | $1,306 | 1.61% |
| Granahan Investment Management | 2,487,673 | $42,016,797 | 1.50% |
| Parkman Healthcare Partners LLC | 224,592 | $3,793,359 | 0.70% |
| PERKINS CAPITAL MANAGEMENT INC | 29,160 | $493 | 0.49% |
| Capital Impact Advisors, LLC | 16,554 | $279,597 | 0.47% |
| Soleus Capital Management, L.P. | 283,500 | $4,788,315 | 0.44% |
| Portolan Capital Management | 253,028 | $4,273,643 | 0.40% |
| Numerai GP LLC | 68,163 | $1,151,273 | 0.38% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 946,620 | $15,988,412 | 0.35% |